Impact of Adjuvant Chemotherapy in Elderly Breast Patients in Taiwan, A Hospital-Based Study |
Lee, Hsiu Chuan
(Department of Internal Medicine, Chi-Mei Medical Center)
Chen, Wei Yu (Department of Internal Medicine, Chi-Mei Medical Center) Huang, Wen Tsung (Department of Surgery, Chi-Mei Medical Center) Cheng, Kuo Chen (Department of Internal Medicine, Chi-Mei Medical Center) Tian, Yu Feng (Department of Surgery, Chi-Mei Medical Center) Ho, Chung Han (Department of Medical Research, Chi-Mei Medical Center) Tsao, Chao Jung (Department of Hematology-Oncology, Chi-Mei Medical Center) Feng, Yin Hsun (Department of Internal Medicine, Chi-Mei Medical Center) |
1 | Elkin EB, Hurria A, Mitra N, Schrag D, Panageas KS (2006) Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. J Clin Oncol, 24, 2757-64. DOI |
2 | Giordano SH, Duan Z, Kuo YF, Hortobagyi GN, Goodwin JS (2006) Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol, 24, 2750-56. DOI |
3 | Jueckstock J, Kasch F, Jaeger B, et al (2015). Adjuvant therapeutic decisions in elderly breast cancer patients: the role of chemotherapy in a retrospective analysis. Arch Gynecol Obstet, 292, 1101-07. DOI |
4 | Karavasilis V, Papadimitriou C, Gogas H, et al (2016). Safety and Tolerability of Anthracycline-Containing Adjuvant Chemotherapy in Elderly High-Risk Breast Cancer Patients. Clin Breast Cancer, 16, 291-98. DOI |
5 | Klepin HD, Pitcher BN, Ballman KV, et al (2014). Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance). J Oncol Pract, 10, 285-92. DOI |
6 | Le Saux O, Ripamonti B, Bruyas A, et al (2015). Optimal management of breast cancer in the elderly patient: current perspectives. Clin Interv Aging, 10, 157-74. |
7 | Leonard R, Ballinger R, Cameron D, et al (2011). Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase? Br J Cancer, 105, 1260-66. DOI |
8 | Muss HB, Berry DA, Cirrincione CT, et al (2009). Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med, 360, 2055-65. DOI |
9 | Pierga JY, Girre V, Laurence V, et al (2004). Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age. Breast, 13, 369-75. DOI |
10 | Rosenstock AS, Lei X, Tripathy D, et al (2016). Short-term mortality in older patients treated with adjuvant chemotherapy for early-stage breast cancer. Breast Cancer Res Treat, 157, 339-50. DOI |
11 | Shen YC, Chang CJ, Hsu C, et al (2005). Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis. Cancer Epidemiol Biomarkers Prev, 14, 1986-90. DOI |
12 | Soubeyran P, Bellera C, Goyard J, et al (2014). Screening for vulnerability in older cancer patients: the Oncodage prospective multicenter cohort study. PLoS One, 9, e115060. DOI |
13 | Torre LA, Bray F, Siegel RL, et al (2015). Global cancer statistics, 2012. CA Cancer J Clin, 65, 87-108. DOI |
14 | Walter LC, Covinsky KE (2001) Cancer screening in elderly patients: a framework for individualized decision making. Jama, 285, 2750-56. DOI |
15 | Westphal T, Rinnerthaler G, Mlineritsch B (2016) Adjuvant medical treatment for breast cancer in elderly and old women. Memo, 9, 17-19. DOI |
16 | Wildiers H, Kunkler I, Biganzoli L, et al (2007). Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol, 8, 1101-15. DOI |
17 | Biganzoli L, Wildiers H, Oakman C, et al (2012). Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol, 13, 148-60. DOI |
18 | Angarita FA, Chesney T, Elser C, et al (2015). Treatment patterns of elderly breast cancer patients at two Canadian cancer centres. Eur J Surg Oncol, 41, 625-34. DOI |
19 | Bastiaannet E, Portielje JE, van de Velde, et al (2011). Lack of survival gain for elderly women with breast cancer. Oncologist, 16, 415-23. DOI |
20 | Bergen ES, Tichy C, Berghoff, et al (2016). Prognostic impact of breast cancer subtypes in elderly patients. Breast Cancer Res Treat, 157, 91-9. DOI |
21 | Crivellari D, Bonetti M, Castiglione-Gertsch, et al (2000). Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J Clin Oncol, 18, 1412-22. DOI |
22 | Collaborative G, Peto R, Davies C, et al (2012). Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet, 379, 432-44. DOI |